| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974542 | The Journal of Heart and Lung Transplantation | 2005 | 5 Pages |
Abstract
The 10-year follow-up of this study suggests that the use of pravastatin in heart transplant patients maintains survival benefit and appears to reduce the development of cardiac allograft vasculopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jon A. MD, Jaime D. MD, Hillel MD, Liane MD, Antoine MD, Michele A. MD, Greg MD, Angela BA, Maria E. BA, Jignesh MD, PhD, Lawrence MD,